🇺🇸 Rifampicin Only Product in Parenteral Dose Form in United States

Rifampicin Only Product in Parenteral Dose Form (Rifampicin Only Product in Parenteral Dose Form) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Rifampicin Only Product in Parenteral Dose Form in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rifampicin Only Product in Parenteral Dose Form approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rifampicin Only Product in Parenteral Dose Form in United States?

Fundacion Clinic per a la Recerca Biomédica is the originator. The local marketing authorisation holder may differ — check the official source linked above.